Search for: "M.D. Janet Woodcock" Results 41 - 47 of 47
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2009, 8:41 am
"The FDA wants patients and health care professionals to know about this risk so they can make informed decisions about treatment," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. [read post]
18 Mar 2009, 11:56 am
According to Janet Woodcock, M.D., director of  the Center for Drug Evaluation and Research at FDA, by means of this action the agency hopes to convey a simple but important message:   "The chronic use of metoclopramide therapy should be avoided in all but rare cases where the benefit is believed to outweigh the risk. [read post]
3 Mar 2009, 3:36 pm
Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research said, “The chronic use of metoclopramide therapy should be avoided in all but rare cases where the benefit is believed to outweigh the risk. [read post]
22 Dec 2008, 5:30 pm
“These tainted weight loss products pose a great risk to public health because they contain undeclared ingredients and, in some cases, contain prescription drugs in amounts that greatly exceed their maximum recommended dosages,” said Janet Woodcock, M.D., director, Center for Drug Evaluation and Research, FDA. [read post]
2 Dec 2008, 6:08 pm
" -- Juanita Hawkins, President, Juanita Hawkins Consulting LLC"[FDA] needs [Janet Woodcock who has a] ... deep history and knowledge of FDA. [read post]
20 Jan 2008, 10:54 pm
"For women that choose to use contraceptives, it is important that they thoroughly discuss with their health care providers the risks and benefits involved," said Janet Woodcock, M.D., the FDA's deputy commissioner for scientific and medical programs, chief medical officer, and acting director of the Center for Drug Evaluation and Research. [read post]